HomeNewsBusinessReal EstateCoronavirus impact | Co-working space providers may reap benefits of social distancing norms

Coronavirus impact | Co-working space providers may reap benefits of social distancing norms

Under a hub-and-spoke model, companies may decide to have a main office, have a few employees continue to work from home and have others in multiple office spaces near home in a flex.

April 23, 2020 / 14:18 IST
Story continues below Advertisement

The COVID-19 pandemic, the subsequent lockdown and now social distancing norms are all set to change the definition of a 'workspace'. Most corporates going forward are likely to evaluate their density plans and seating arrangements in a conventional office.

Many of them are actually considering splitting their office into two or more locations to minimize future risk and also reduce dependency on one office, so much so that many are currently in talks with co-workspace providers for taking up space in multiple smaller offices across the city.

Story continues below Advertisement

The day is not far when the main corporate offices may become a strategic space, some people will continue to work from home and some may be asked to work near home in a flex, said co-working space providers.

The idea is to have one of the locations in the same city up and running so that businesses are not impacted even if one zone is quarantined or is declared a hotspot.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show